This report contains market size and forecasts of Genital Herpes Research and Development Pipeline in Global, including the following market information:
Global Genital Herpes Research and Development Pipeline Market Size 2024-2030, ($ millions)
The global Genital Herpes Research and Development Pipeline market is projected to reach US$ million by 2029.
We surveyed the Genital Herpes Research and Development Pipeline companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Genital Herpes Research and Development Pipeline Market, by Type, 2024-2030 ($ millions)
Global Genital Herpes Research and Development Pipeline Market Segment Percentages, by Type
Acyclovir
Aspidasept
G-103
GEN-003
GV-2207
HerpeCide-I
HSV-529
Pritelivir
SB-105A10
Global Genital Herpes Research and Development Pipeline Market, by Application, 2024-2030 ($ millions)
Global Genital Herpes Research and Development Pipeline Market Segment Percentages, by Application
Hospital
Clinic
Global Genital Herpes Research and Development Pipeline Market, By Region and Country, 2024-2030 ($ Millions)
Global Genital Herpes Research and Development Pipeline Market Segment Percentages, by region and country
United States
Europe
Asia
China
Rest of World
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
AiCuris GmbH & Co. KG
AlphaVax, Inc.
Foamix Pharmaceuticals Ltd.
Genocea Biosciences, Inc.
GenVec, Inc.
Immune Design Corp.
Immunovaccine, Inc.
Mymetics Corporation
NanoBio Corporation
NanoViricides, Inc.
PaxVax
Profectus BioSciences, Inc.
Sanofi Pasteur SA
Spider Biotech
Starpharma Holdings Limited
Vaccibody AS
Vaxart, Inc.
Vical Incorporated.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Genital Herpes Research and Development Pipeline Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Genital Herpes Research and Development Pipeline Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Genital Herpes Research and Development Pipeline Overall Market Size
2.1 Global Genital Herpes Research and Development Pipeline Market Size: 2023 VS 2030
2.2 Global Genital Herpes Research and Development Pipeline Market Size, Prospects & Forecasts: 2023-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key Genital Herpes Research and Development Pipeline Players in Global Market
3.2 Global Companies Genital Herpes Research and Development Pipeline Product & Technology
4 Genital Herpes Research and Development Pipeline Companies Profiles
4.1 AiCuris GmbH & Co. KG
4.1.1 AiCuris GmbH & Co. KG Company Summary
4.1.2 AiCuris GmbH & Co. KG Business Overview
4.1.3 AiCuris GmbH & Co. KG Genital Herpes Research and Development Pipeline Product Offerings & Technology
4.1.4 AiCuris GmbH & Co. KG Genital Herpes Research and Development Pipeline R&D, and Plans
4.2 AlphaVax, Inc.
4.2.1 AlphaVax, Inc. Company Summary
4.2.2 AlphaVax, Inc. Business Overview
4.2.3 AlphaVax, Inc. Genital Herpes Research and Development Pipeline Product Offerings & Technology
4.2.4 AlphaVax, Inc. Genital Herpes Research and Development Pipeline R&D, and Plans
4.3 Foamix Pharmaceuticals Ltd.
4.3.1 Foamix Pharmaceuticals Ltd. Company Summary
4.3.2 Foamix Pharmaceuticals Ltd. Business Overview
4.3.3 Foamix Pharmaceuticals Ltd. Genital Herpes Research and Development Pipeline Product Offerings & Technology
4.3.4 Foamix Pharmaceuticals Ltd. Genital Herpes Research and Development Pipeline R&D, and Plans
4.4 Genocea Biosciences, Inc.
4.4.1 Genocea Biosciences, Inc. Company Summary
4.4.2 Genocea Biosciences, Inc. Business Overview
4.4.3 Genocea Biosciences, Inc. Genital Herpes Research and Development Pipeline Product Offerings & Technology
4.4.4 Genocea Biosciences, Inc. Genital Herpes Research and Development Pipeline R&D, and Plans
4.5 GenVec, Inc.
4.5.1 GenVec, Inc. Company Summary
4.5.2 GenVec, Inc. Business Overview
4.5.3 GenVec, Inc. Genital Herpes Research and Development Pipeline Product Offerings & Technology
4.5.4 GenVec, Inc. Genital Herpes Research and Development Pipeline R&D, and Plans
4.6 Immune Design Corp.
4.6.1 Immune Design Corp. Company Summary
4.6.2 Immune Design Corp. Business Overview
4.6.3 Immune Design Corp. Genital Herpes Research and Development Pipeline Product Offerings & Technology
4.6.4 Immune Design Corp. Genital Herpes Research and Development Pipeline R&D, and Plans
4.7 Immunovaccine, Inc.
4.7.1 Immunovaccine, Inc. Company Summary
4.7.2 Immunovaccine, Inc. Business Overview
4.7.3 Immunovaccine, Inc. Genital Herpes Research and Development Pipeline Product Offerings & Technology
4.7.4 Immunovaccine, Inc. Genital Herpes Research and Development Pipeline R&D, and Plans
4.8 Mymetics Corporation
4.8.1 Mymetics Corporation Company Summary
4.8.2 Mymetics Corporation Business Overview
4.8.3 Mymetics Corporation Genital Herpes Research and Development Pipeline Product Offerings & Technology
4.8.4 Mymetics Corporation Genital Herpes Research and Development Pipeline R&D, and Plans
4.9 NanoBio Corporation
4.9.1 NanoBio Corporation Company Summary
4.9.2 NanoBio Corporation Business Overview
4.9.3 NanoBio Corporation Genital Herpes Research and Development Pipeline Product Offerings & Technology
4.9.4 NanoBio Corporation Genital Herpes Research and Development Pipeline R&D, and Plans
4.10 NanoViricides, Inc.
4.10.1 NanoViricides, Inc. Company Summary
4.10.2 NanoViricides, Inc. Business Overview
4.10.3 NanoViricides, Inc. Genital Herpes Research and Development Pipeline Product Offerings & Technology
4.10.4 NanoViricides, Inc. Genital Herpes Research and Development Pipeline R&D, and Plans
4.11 PaxVax
4.11.1 PaxVax Company Summary
4.11.2 PaxVax Business Overview
4.11.3 PaxVax Genital Herpes Research and Development Pipeline Product Offerings & Technology
4.11.4 PaxVax Genital Herpes Research and Development Pipeline R&D, and Plans
4.12 Profectus BioSciences, Inc.
4.12.1 Profectus BioSciences, Inc. Company Summary
4.12.2 Profectus BioSciences, Inc. Business Overview
4.12.3 Profectus BioSciences, Inc. Genital Herpes Research and Development Pipeline Product Offerings & Technology
4.12.4 Profectus BioSciences, Inc. Genital Herpes Research and Development Pipeline R&D, and Plans
4.13 Sanofi Pasteur SA
4.13.1 Sanofi Pasteur SA Company Summary
4.13.2 Sanofi Pasteur SA Business Overview
4.13.3 Sanofi Pasteur SA Genital Herpes Research and Development Pipeline Product Offerings & Technology
4.13.4 Sanofi Pasteur SA Genital Herpes Research and Development Pipeline R&D, and Plans
4.14 Spider Biotech
4.14.1 Spider Biotech Company Summary
4.14.2 Spider Biotech Business Overview
4.14.3 Spider Biotech Genital Herpes Research and Development Pipeline Product Offerings & Technology
4.14.4 Spider Biotech Genital Herpes Research and Development Pipeline R&D, and Plans
4.15 Starpharma Holdings Limited
4.15.1 Starpharma Holdings Limited Company Summary
4.15.2 Starpharma Holdings Limited Business Overview
4.15.3 Starpharma Holdings Limited Genital Herpes Research and Development Pipeline Product Offerings & Technology
4.15.4 Starpharma Holdings Limited Genital Herpes Research and Development Pipeline R&D, and Plans
4.16 Vaccibody AS
4.16.1 Vaccibody AS Company Summary
4.16.2 Vaccibody AS Business Overview
4.16.3 Vaccibody AS Genital Herpes Research and Development Pipeline Product Offerings & Technology
4.16.4 Vaccibody AS Genital Herpes Research and Development Pipeline R&D, and Plans
4.17 Vaxart, Inc.
4.17.1 Vaxart, Inc. Company Summary
4.17.2 Vaxart, Inc. Business Overview
4.17.3 Vaxart, Inc. Genital Herpes Research and Development Pipeline Product Offerings & Technology
4.17.4 Vaxart, Inc. Genital Herpes Research and Development Pipeline R&D, and Plans
4.18 Vical Incorporated.
4.18.1 Vical Incorporated. Company Summary
4.18.2 Vical Incorporated. Business Overview
4.18.3 Vical Incorporated. Genital Herpes Research and Development Pipeline Product Offerings & Technology
4.18.4 Vical Incorporated. Genital Herpes Research and Development Pipeline R&D, and Plans
5 Sights by Region
5.1 By Region - Global Genital Herpes Research and Development Pipeline Market Size, 2024 & 2030
5.2 By Region - Global Genital Herpes Research and Development Pipeline Revenue, (2024-2030)
5.3 United States
5.3.1 Key Players of Genital Herpes Research and Development Pipeline in United States
5.3.2 United States Genital Herpes Research and Development Pipeline Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of Genital Herpes Research and Development Pipeline in Europe
5.4.2 Europe Genital Herpes Research and Development Pipeline Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of Genital Herpes Research and Development Pipeline in China
5.5.2 China Genital Herpes Research and Development Pipeline Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 By Type - Global Genital Herpes Research and Development Pipeline Market Size Markets, 2024 & 2030
6.2 Acyclovir
6.3 Aspidasept
6.4 G-103
6.5 GEN-003
6.6 GV-2207
6.7 HerpeCide-I
6.8 HSV-529
6.9 Pritelivir
6.10 SB-105A10
7 Sights by Application
7.1 By Application - Global Genital Herpes Research and Development Pipeline Market Size, 2024 & 2030
7.2 Hospital
7.3 Clinic
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Genital Herpes Research and Development Pipeline Market Opportunities & Trends in Global Market
Table 2. Genital Herpes Research and Development Pipeline Market Drivers in Global Market
Table 3. Genital Herpes Research and Development Pipeline Market Restraints in Global Market
Table 4. Key Players of Genital Herpes Research and Development Pipeline in Global Market
Table 5. Global Companies Genital Herpes Research and Development Pipeline Product & Technology
Table 6. AiCuris GmbH & Co. KG Company Summary
Table 7. AiCuris GmbH & Co. KG Genital Herpes Research and Development Pipeline Product Offerings
Table 8. AlphaVax, Inc. Company Summary
Table 9. AlphaVax, Inc. Genital Herpes Research and Development Pipeline Product Offerings
Table 10. Foamix Pharmaceuticals Ltd. Company Summary
Table 11. Foamix Pharmaceuticals Ltd. Genital Herpes Research and Development Pipeline Product Offerings
Table 12. Genocea Biosciences, Inc. Company Summary
Table 13. Genocea Biosciences, Inc. Genital Herpes Research and Development Pipeline Product Offerings
Table 14. GenVec, Inc. Company Summary
Table 15. GenVec, Inc. Genital Herpes Research and Development Pipeline Product Offerings
Table 16. Immune Design Corp. Company Summary
Table 17. Immune Design Corp. Genital Herpes Research and Development Pipeline Product Offerings
Table 18. Immunovaccine, Inc. Company Summary
Table 19. Immunovaccine, Inc. Genital Herpes Research and Development Pipeline Product Offerings
Table 20. Mymetics Corporation Company Summary
Table 21. Mymetics Corporation Genital Herpes Research and Development Pipeline Product Offerings
Table 22. NanoBio Corporation Company Summary
Table 23. NanoBio Corporation Genital Herpes Research and Development Pipeline Product Offerings
Table 24. NanoViricides, Inc. Company Summary
Table 25. NanoViricides, Inc. Genital Herpes Research and Development Pipeline Product Offerings
Table 26. PaxVax Company Summary
Table 27. PaxVax Genital Herpes Research and Development Pipeline Product Offerings
Table 28. Profectus BioSciences, Inc. Company Summary
Table 29. Profectus BioSciences, Inc. Genital Herpes Research and Development Pipeline Product Offerings
Table 30. Sanofi Pasteur SA Company Summary
Table 31. Sanofi Pasteur SA Genital Herpes Research and Development Pipeline Product Offerings
Table 32. Spider Biotech Company Summary
Table 33. Spider Biotech Genital Herpes Research and Development Pipeline Product Offerings
Table 34. Starpharma Holdings Limited Company Summary
Table 35. Starpharma Holdings Limited Genital Herpes Research and Development Pipeline Product Offerings
Table 36. Vaccibody AS Company Summary
Table 37. Vaccibody AS Genital Herpes Research and Development Pipeline Product Offerings
Table 38. Vaxart, Inc. Company Summary
Table 39. Vaxart, Inc. Genital Herpes Research and Development Pipeline Product Offerings
Table 40. Vical Incorporated. Company Summary
Table 41. Vical Incorporated. Genital Herpes Research and Development Pipeline Product Offerings
Table 42. By Region? Global Genital Herpes Research and Development Pipeline Revenue, (US$, Mn), 2024 & 2030
Table 43. By Region - Global Genital Herpes Research and Development Pipeline Revenue, (US$, Mn), 2024-2030
Table 44. By Type ? Global Genital Herpes Research and Development Pipeline Market Size, (US$, Mn), 2024 & 2030
Table 45. By Application? Global Genital Herpes Research and Development Pipeline Market Size, (US$, Mn), 2024 & 2030
List of Figures
Figure 1. Genital Herpes Research and Development Pipeline Segment by Type in 2030
Figure 2. Genital Herpes Research and Development Pipeline Segment by Application in 2030
Figure 3. Global Genital Herpes Research and Development Pipeline Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Genital Herpes Research and Development Pipeline Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Genital Herpes Research and Development Pipeline Revenue, 2017-2028 (US$, Mn)
Figure 7. By Region - Global Genital Herpes Research and Development Pipeline Revenue Market Share, 2024-2030
Figure 8. By Type - Global Genital Herpes Research and Development Pipeline Revenue Market Share, 2024-2030
Figure 9. By Application - Global Genital Herpes Research and Development Pipeline Revenue Market Share, 2024-2030
